Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @biogen
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @biogen
-
Professor Wolfgang Müller-Felber will shortly be taking to the stage at
#SMAcongress2020 to talk about the importance of newborn screening in#SMA patients. Join us in the auditorium!#Evry2020#SpinalMuscularAtrophypic.twitter.com/7XAMmDVhR7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The
@SMAEurope congress has begun! Stop by booth 4 to find out more about why newborn screening is critical for#SpinalMuscularAtrophy patients.#Evry2020#SMAcongress2020#SMApic.twitter.com/WsJ0Vkrvcv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Diagnosing
#SpinalMuscularAtrophy (#SMA) early, before irreversible damage occurs, is critical. Newborn screening means a diagnosis can happen before any symptoms or damage occurs!#Evry2020#SMAcongress2020pic.twitter.com/aBXlvUOgig
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are proud to be taking part in the
@SMAEurope congress which starts this week! Check out what’s going on in the program: http://ow.ly/KxGJ50yc0Z6#Evry2020#SMAcongress2020#SpinalMuscularAtrophy#SMApic.twitter.com/Y2mlWODyl1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
For more than 20 years, Biogen has pioneered the development of multiple sclerosis (
#MS) treatments. Our pipeline continues to innovate and improve outcomes for the#MScommunity.pic.twitter.com/6BeCfsV2vfHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are proud to have been awarded a Gold Medal in the
#2020SAMYearbook for our#sustainability efforts. Learn more here: http://ow.ly/5NjD50yaipS pic.twitter.com/cN67Ck71s5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our fourth quarter and full year 2019 financial results webcast replay is now available:http://media.biogen.com/events-and-presentations/upcoming-events …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Listen live to our fourth quarter and full year 2019 financial results webcast starting at 8:00 AM ET:http://media.biogen.com/events-and-presentations/upcoming-events …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Read our fourth quarter and full year 2019 financial results here:http://media.biogen.com/news
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
For the third consecutive year, we are proud to rank in the
@CDP 's Leadership category for our climate efforts. Read more here: http://ow.ly/udF250y8s7PHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Attending
@CBI_Conferences's Patient Registries & Real World Evidence Summit in Miami? Join our own Charles Makin’s keynote presentation to learn more about collecting and interpreting clinical data. https://informaconnect.com/patient-registries-real-world-evidence-rwe-and-health-economic-outcomes-research-heor/ …pic.twitter.com/W1UlkmFotv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In a conversation about Alzheimer’s disease our CEO, Michel Vounatsos, emphasized that the time to act is now. http://ow.ly/WqrH50y4pmd
#wef20pic.twitter.com/6A9rmfsw96
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Living with
#MS? It’s important to pay attention to symptoms and consult with your doctor. https://www.biogen.com/en_us/multiple-sclerosis.html …pic.twitter.com/VnqBMxOvNnHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are proud to award Golden Tickets to
@lucytherapeutix@GCTherapeutics and Rgenta Therapeutics, who will receive lab space for one year at@labcentral– a launchpad for high-potential start ups. Congratulations! https://labcentral.org pic.twitter.com/EdiOnCex5V
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are proud to be named on the
@HRC Equality Index as one of the best places to work for LGBTQ equality.pic.twitter.com/ZQfiYTkCew
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Nearly 1 million people in the United States are living with Multiple Sclerosis (
#MS). We are committed to advancing treatment for the#MScommunity. https://www.biogen.com/en_us/multiple-sclerosis.html …pic.twitter.com/7B5i2GYkfHHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are proud to receive a 100% on the 2020
@HRC’s Corporate Equality Index for the 7th year. We are committed to supporting LGBTQ+ workplace#diversity and equality.pic.twitter.com/ytHDEqudqX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are committed to supporting our colleagues, families, friends and communities who may have been impacted by the Australian wildfires. A special thank you to our Australian affiliate employees for using their volunteering leave to provide relief efforts in the area.pic.twitter.com/bIcL3LU6Q4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
James was diagnosed with choroideremia (CHM) at age 7 and has seen his field of vision decrease significantly every year. Learn more about his story. https://www.biogen.com/en_us/stories/james_story.html …pic.twitter.com/f2WqlHVS1n
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Looking back on an impactful year, we are proud of all the milestones, achievements and pioneering work done globally.
#ProudMoments2019pic.twitter.com/9nqNXgNPMjHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.